lncRNA 00312 Attenuates Cell Proliferation and Invasion and Promotes Apoptosis in Renal Cell Carcinoma via miR-34a-5p/ASS1 Axis

Table 1

Association between lncRNA 00312 expression and clinicopathological characteristics in 47 renal cell carcinoma patients.

Variable	lncRNA 00312 expression			value
	Low expression; ()	High expression; ()
Age (years)			0.151	0.881
<60	12	14	0.010	0.920
≥60	10	11
Gender
Male	13	17	0.402	0.526
Female	9	8
Pathological grade
I–II	6	15	5.071	0.024
III–IV	16	10
Lymph node involvement
NO-N1	9	11	0.046	0.830
N2-NX	13	14
Distant metastasis
Absent	8	10	0.065	0.798
Present	14	15
Tumor size
T1-T2	8	17	4.704	0.030
T3-T4	14	8
TNM stage
I-II	7	16	4.850	0.028
III-IV	15	9
ACR (mg/g)			-0.178	0.860
<30	14	16	0.078	0.781
≥30	8	9
eGFR (mL/min/1.73m^2)			0.484	0.631
≥60	16	18	0.074	0.786
<60	6	7
Cr (μmol/L)			-0.107	0.916
<82.1 (F)/97.0 (M)	18	20	0.046	0.831
≥82.1 (F)/97.0 (M)	4	5
CysC (mg/L)			-0.115	0.909
<1.09	17	18	0.006	0.938
≥1.09	5	7

Note: Statistical value by an independent samples -test. The others were values by a chi-square test. eGFR: estimated glomerular filtration rate; ACR: urine albumin-creatinine ratio; CysC: cystatin C; Cr: creatinine; F: female; M: male.